產品描述: CH-223191 is a potent and specific antagonist of aryl hydrocarbon receptor (AhR). CH-223191 inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibits TCDD-induced luciferase activity with an IC50 of 0.03 μM |
靶點:
Aryl Hydrocarbon Receptor;AhR;ArylHydrocarbonReceptor |
體內研究:
CH-223191 (10 mg/kg; once a day; 25 days) suppresses cytochrome P450 1A1 expression and the intrahepatocyte fat content in liver, reduces activity of AST and ALT in TCDD-treated mice |
參考文獻:
1. Kim SH, et al. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol. 2006 Jun;69(6):1871-8. Epub 2006 Mar |
溶解性:
DMSO : 62.5 mg/mL (187.47 mM; ultrasonic and warming and heat to 60°C) |
保存條件:
2-8℃ |
配置溶液濃度參考:
|
1mg |
5mg |
10mg |
1 mM |
2.999 ml |
14.997 ml |
29.995 ml |
5 mM |
0.6 ml |
2.999 ml |
5.999 ml |
10 mM |
0.3 ml |
1.5 ml |
2.999 ml |
50 mM |
0.06 ml |
0.3 ml |
0.6 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |